JP2015535839A5 - - Google Patents

Download PDF

Info

Publication number
JP2015535839A5
JP2015535839A5 JP2015533635A JP2015533635A JP2015535839A5 JP 2015535839 A5 JP2015535839 A5 JP 2015535839A5 JP 2015533635 A JP2015533635 A JP 2015533635A JP 2015533635 A JP2015533635 A JP 2015533635A JP 2015535839 A5 JP2015535839 A5 JP 2015535839A5
Authority
JP
Japan
Prior art keywords
alkyl
carboxylic acid
compound
amino
heteroarylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015533635A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015535839A (ja
JP6298998B2 (ja
Filing date
Publication date
Priority claimed from EP12306196.2A external-priority patent/EP2712866A1/en
Application filed filed Critical
Publication of JP2015535839A publication Critical patent/JP2015535839A/ja
Publication of JP2015535839A5 publication Critical patent/JP2015535839A5/ja
Application granted granted Critical
Publication of JP6298998B2 publication Critical patent/JP6298998B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015533635A 2012-10-01 2013-10-01 ウイルス感染を治療するための1,2,4−トリアジン誘導体 Expired - Fee Related JP6298998B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306196.2 2012-10-01
EP12306196.2A EP2712866A1 (en) 2012-10-01 2012-10-01 1,2,4-triazine derivatives for the treatment of viral infections
PCT/EP2013/070488 WO2014053516A1 (en) 2012-10-01 2013-10-01 1,2,4-triazine derivatives for the treatment of viral infections.

Publications (3)

Publication Number Publication Date
JP2015535839A JP2015535839A (ja) 2015-12-17
JP2015535839A5 true JP2015535839A5 (enExample) 2016-11-10
JP6298998B2 JP6298998B2 (ja) 2018-03-28

Family

ID=46982496

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015533635A Expired - Fee Related JP6298998B2 (ja) 2012-10-01 2013-10-01 ウイルス感染を治療するための1,2,4−トリアジン誘導体

Country Status (21)

Country Link
US (1) US9416114B2 (enExample)
EP (2) EP2712866A1 (enExample)
JP (1) JP6298998B2 (enExample)
KR (1) KR102138393B1 (enExample)
CN (1) CN104812747B (enExample)
AU (1) AU2013326579B2 (enExample)
BR (1) BR112015007310B1 (enExample)
CA (1) CA2886630C (enExample)
CL (1) CL2015000787A1 (enExample)
EA (1) EA026236B1 (enExample)
ES (1) ES2616496T3 (enExample)
IL (1) IL237871A (enExample)
IN (1) IN2015DN03327A (enExample)
MX (1) MX348229B (enExample)
MY (1) MY182558A (enExample)
NZ (1) NZ706354A (enExample)
PH (1) PH12015500724B1 (enExample)
SG (1) SG11201502522WA (enExample)
UA (1) UA114644C2 (enExample)
WO (1) WO2014053516A1 (enExample)
ZA (1) ZA201502240B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2691745T3 (es) 2011-04-08 2018-11-28 Janssen Sciences Ireland Uc Derivados de pirimidina para el tratamiento de infecciones víricas
DK2776439T3 (en) 2011-11-09 2018-10-22 Janssen Sciences Ireland Uc PURINE DERIVATIVES FOR TREATING VIRUS INFECTIONS
DK2872515T3 (en) 2012-07-13 2016-09-19 Janssen Sciences Ireland Uc MACROCYCLIC PURINES FOR TREATING VIRUS INFECTIONS
MX386924B (es) 2012-10-10 2025-03-19 Janssen Sciences Ireland Uc Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades.
US9663474B2 (en) 2012-11-16 2017-05-30 Janssen Sciences Ireland Uc Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
KR102300861B1 (ko) 2013-02-21 2021-09-10 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
WO2014154859A1 (en) 2013-03-29 2014-10-02 Janssen R&D Ireland Macrocyclic deaza-purinones for the treatment of viral infections
UA117586C2 (uk) 2013-05-24 2018-08-27 ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі Похідні піридину для лікування вірусних інфекцій та інших захворювань
MX392130B (es) 2013-06-27 2025-03-21 Janssen Sciences Ireland Uc Derivados de pirrolo[3,2-d]pirimidina para el tratamiento de infecciones víricas y otras enfermedades.
ES2836881T3 (es) 2013-07-30 2021-06-28 Janssen Sciences Ireland Unlimited Co Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales
MA45539A (fr) 2016-07-01 2019-05-08 Janssen Sciences Ireland Unlimited Co Dihydropyranopyrimidines pour le traitement d'infections virales
SG10202010317VA (en) * 2016-09-29 2020-11-27 Janssen Sciences Ireland Unlimited Co Pyrimidine prodrugs for the treatment of viral infections and further diseases
TW202415645A (zh) 2018-03-01 2024-04-16 愛爾蘭商健生科學愛爾蘭無限公司 2,4-二胺基喹唑啉衍生物及其醫學用途
BR112021015577A2 (pt) 2019-02-08 2021-10-05 Research & Business Foundation Sungkyunkwan University Complexo-colesterol agonista do receptor toll-like 7 ou 8 e uso do mesmo
CN115666637A (zh) 2020-03-02 2023-01-31 蛋白科技先锋 基于病原体细胞壁骨架的模拟活病原体的纳米粒子及其制备方法
WO2022031021A1 (ko) 2020-08-04 2022-02-10 성균관대학교산학협력단 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
EP4194008A4 (en) 2020-08-04 2025-01-08 Progeneer Inc. Kinetically acting adjuvant ensemble
US20230277525A1 (en) 2020-08-04 2023-09-07 Progeneer Inc Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof
US20260076973A1 (en) * 2023-01-15 2026-03-19 Viradem, Inc. Compounds and methods for treating diseases caused by SARS-CoV-2 and other coronaviruses
WO2025110816A1 (ko) 2023-11-23 2025-05-30 프로지니어 주식회사 암의 치료를 위한 활성화 부위가 일시적으로 비활성화된 톨-유사 수용체 7 또는 8 작용자와 항암 치료의 병용요법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485531A1 (fr) * 1980-06-25 1981-12-31 Fabre Sa Pierre Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
JP4667543B2 (ja) 1996-07-03 2011-04-13 大日本住友製薬株式会社 新規プリン誘導体
JP4375901B2 (ja) 1997-11-28 2009-12-02 大日本住友製薬株式会社 新規な複素環化合物
AU2005271161B2 (en) * 2004-08-10 2011-05-12 Janssen Pharmaceutica N.V. HIV inhibiting 1,2,4-triazin-6-one derivatives
EA200702235A1 (ru) 2005-05-04 2008-04-28 Пфайзер Лимитед Производные 2-амидо-6-амино-8-оксопурина в качестве модуляторов toll-подобных рецепторов для лечения рака и вирусных инфекций, таких как гепатит с
ES2612890T3 (es) * 2005-09-01 2017-05-19 F. Hoffmann-La Roche Ag Diaminopirimidinas como moduladores de P2X3 y P2X2/3
RU2352565C1 (ru) * 2007-10-08 2009-04-20 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" 3-амино-6-ароилметил-5-гидрокси-1,2,4-триазины и способ их получения
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
WO2012067269A1 (en) * 2010-11-19 2012-05-24 Dainippon Sumitomo Pharma Co., Ltd. Aminoalkoxyphenyl compounds and their use in the treatment of disease

Similar Documents

Publication Publication Date Title
HRP20200538T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
SI2906563T1 (en) Derivatives of pyrrolo (3,2-d) pyrimidine for the treatment of viral infections and other diseases
PH12019502370A1 (en) Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same
JP2015537020A5 (enExample)
NZ627036A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HRP20180447T1 (hr) Derivati kinazolina za liječenje virusnih infekcija i drugih bolesti
JP2016530259A5 (enExample)
JP2016519165A5 (enExample)
EP3954679A3 (en) Amide compounds for the treatment of hiv infections
JP2016540742A5 (enExample)
JP2017523225A5 (enExample)
RU2014141579A (ru) Гетероциклические соединения в качестве ингибиторов бета-лактамаз
JP2014514360A5 (enExample)
JP2016522172A5 (enExample)
JP2014506907A5 (enExample)
JP2017533968A5 (enExample)
JP2015509535A5 (enExample)
JP2016518305A5 (enExample)
JP2015520140A5 (enExample)
JP2016535732A5 (enExample)
JP2015535847A5 (enExample)
JP2018502101A5 (enExample)
JP2018529690A5 (enExample)
JP2017517565A5 (enExample)
JP2020527175A5 (enExample)